India cricketers Yashasvi Jaiswal and Shafali Verma have reportedly received their first “missed test” notices from the National Anti-Doping Agency (NADA) after failing to be available for scheduled out-of-competition dope tests at their declared locations. According to sources quoted by India Today, both players have now been asked to submit explanations, while the Board of Control for Cricket in India (BCCI) has also been informed about the development.
This is the first recorded whereabouts failure for both cricketers, who are currently part of NADA’s Registered Testing Pool (RTP). Under NADA regulations, athletes included in the RTP must regularly update their whereabouts and provide a one-hour time slot during which they are available for surprise dope testing. A Doping Control Officer (DCO) can visit during that period to collect samples. Failure to be present at the declared location results in a “missed test” notice under anti-doping rules.
Reports claim that Jaiswal’s scheduled test took place on December 17 last year, while Shafali Verma’s test was conducted on November 7. In both instances, the players were reportedly unavailable at the addresses they had submitted.
ALSO READ: Krunal Pandya Reacts After Nicholas Pooran Banter Sparks IPL 2026 Buzz
NADA later contacted the players on February 18 and February 20, respectively, seeking explanations for the missed tests. However, neither player reportedly responded within the stipulated timeline, resulting in the first whereabouts failures being recorded.
Importantly, a single missed test does not amount to a doping offence. According to anti-doping guidelines, three whereabouts failures within a 12-month period can trigger disciplinary action and may result in a suspension of up to two years if the athlete fails to provide a satisfactory explanation before the hearing panel.
The issue comes at a crucial stage for both players. Jaiswal is currently representing Rajasthan Royals in IPL 2026 and remains one of India’s most promising young batters. Meanwhile, Shafali Verma continues to be a key member of the Indian women’s setup ahead of the Women’s T20 World Cup in England and Wales starting June 12.
ALSO READ: Sanju Samson Emerges Ahead Of Shreyas Iyer In India T20I Captaincy Race
The development also brings back memories of Prithvi Shaw’s 2019 doping case, where the former India opener served an eight-month suspension after testing positive for Terbutaline, a prohibited substance found in cough syrup.
At present, neither Jaiswal nor Shafali faces an anti-doping violation, but the notices underline NADA’s strict compliance policies and the growing importance of whereabouts monitoring in international cricket.
